BiotechTube
Home/Novita Pharmaceuticals/Christy Y. Shue
CY

Christy Y. Shue

Chief Financial Officer

Novita Pharmaceuticals

Therapeutic Areas

OncologyInfectious DiseasesNeurological Degenerative Diseases

Novita Pharmaceuticals Pipeline

DrugIndicationPhase
NP-G2-044Advanced/Metastatic Solid Tumor Malignancies (Monotherapy)Phase 2a
NP-G2-044 + anti-PD-1 InhibitorsSolid TumorsPhase 2a
NP-G2-044 + Chemotherapy AgentsOvarian CancerPhase 2a

Leadership Team at Novita Pharmaceuticals

SC
Stewart Campbell
Chief Executive Officer, Board Member
JZ
Jillian Zhang
President, Chief Scientific Officer, Co-Founder, Board Director
XH
Xin-Yun Huang
Co-Founder
View full Novita Pharmaceuticals profile